
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7607690
[patent_doc_number] => 07098024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Depsipeptide compound'
[patent_app_type] => utility
[patent_app_number] => 10/684656
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5149
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10684656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/684656 | Depsipeptide compound | Oct 14, 2003 | Issued |
Array
(
[id] => 4866833
[patent_doc_number] => 20080145892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Genes and Proteins For the Biosynthesis of the Glycopeptide Antibiotic A40926'
[patent_app_type] => utility
[patent_app_number] => 10/532567
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14088
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10532567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532567 | Genes and Proteins For the Biosynthesis of the Glycopeptide Antibiotic A40926 | Oct 14, 2003 | Abandoned |
Array
(
[id] => 7385822
[patent_doc_number] => 20040082518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'New use of melagatran'
[patent_app_type] => new
[patent_app_number] => 10/685003
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2425
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685003 | New use of melagatran | Oct 14, 2003 | Abandoned |
Array
(
[id] => 7385791
[patent_doc_number] => 20040082514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Methods for treatment of helicobacter pylori-associated disorders'
[patent_app_type] => new
[patent_app_number] => 10/682937
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10075
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10682937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/682937 | Methods for treatment of Helicobacter pylori-associated disorders | Oct 13, 2003 | Issued |
Array
(
[id] => 132388
[patent_doc_number] => 07695949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Process for producing a target fermentation product'
[patent_app_type] => utility
[patent_app_number] => 10/681086
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 7529
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/695/07695949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10681086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/681086 | Process for producing a target fermentation product | Oct 7, 2003 | Issued |
Array
(
[id] => 74272
[patent_doc_number] => 07749960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Osteoprotegerin in milk'
[patent_app_type] => utility
[patent_app_number] => 10/676358
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5082
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10676358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/676358 | Osteoprotegerin in milk | Oct 1, 2003 | Issued |
Array
(
[id] => 7336743
[patent_doc_number] => 20040132654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto'
[patent_app_type] => new
[patent_app_number] => 10/670563
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10670563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/670563 | Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto | Sep 25, 2003 | Issued |
Array
(
[id] => 612644
[patent_doc_number] => 07148041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Animal product free media and processes for obtaining a botulinum toxin'
[patent_app_type] => utility
[patent_app_number] => 10/672876
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10138
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10672876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/672876 | Animal product free media and processes for obtaining a botulinum toxin | Sep 24, 2003 | Issued |
Array
(
[id] => 7275637
[patent_doc_number] => 20040235088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Process for the production of ergosterol and its intermediate products using recombinant yeasts'
[patent_app_type] => new
[patent_app_number] => 10/665449
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6299
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665449 | Process for the production of ergosterol and its intermediate products using recombinant yeasts | Sep 21, 2003 | Abandoned |
Array
(
[id] => 7097319
[patent_doc_number] => 20050129777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Elemental nanoparticles of substantially water insoluble materials'
[patent_app_type] => utility
[patent_app_number] => 10/667738
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3941
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667738 | Elemental nanoparticles of substantially water insoluble materials | Sep 21, 2003 | Abandoned |
Array
(
[id] => 442078
[patent_doc_number] => 07255866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Botulinum toxin therapy for fibromyalgia'
[patent_app_type] => utility
[patent_app_number] => 10/666408
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10869
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/255/07255866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10666408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/666408 | Botulinum toxin therapy for fibromyalgia | Sep 17, 2003 | Issued |
Array
(
[id] => 7307620
[patent_doc_number] => 20040142037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Lactoferrin compositions and methods of wound treatment'
[patent_app_type] => new
[patent_app_number] => 10/663258
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17761
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10663258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663258 | Lactoferrin compositions and methods of wound treatment | Sep 15, 2003 | Issued |
Array
(
[id] => 7443746
[patent_doc_number] => 20040185737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Non-woven fabric comprising ultra-fine fiber of silk fibroin and/or silk-like material, and method for production thereof'
[patent_app_type] => new
[patent_app_number] => 10/471587
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5200
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471587 | Non-woven fabric comprising ultra-fine fiber of silk fibroin and/or silk-like material, and method for production thereof | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7677720
[patent_doc_number] => 20040152106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Gene necessary for striatal function, uses thereof, and compounds for modulating same'
[patent_app_type] => new
[patent_app_number] => 10/659770
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 19210
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10659770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/659770 | Gene necessary for striatal function, uses thereof, and compounds for modulating same | Sep 9, 2003 | Abandoned |
Array
(
[id] => 8270500
[patent_doc_number] => 08212003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/526682
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2451
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10526682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526682 | Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof | Sep 2, 2003 | Issued |
Array
(
[id] => 7676941
[patent_doc_number] => 20040152885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Lp mammalian proteins; related reagents'
[patent_app_type] => new
[patent_app_number] => 10/480172
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96139
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480172 | Lp mammalian proteins; related reagents | Aug 26, 2003 | Abandoned |
Array
(
[id] => 809912
[patent_doc_number] => 07416870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => 'Methods of directing C-O bond formation utilizing a type II polyketide synthase system'
[patent_app_type] => utility
[patent_app_number] => 10/646664
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19898
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10646664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/646664 | Methods of directing C-O bond formation utilizing a type II polyketide synthase system | Aug 21, 2003 | Issued |
Array
(
[id] => 425260
[patent_doc_number] => 07271243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Full-length human cDNAs encoding potentially secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 10/643836
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 267100
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643836 | Full-length human cDNAs encoding potentially secreted proteins | Aug 18, 2003 | Issued |
Array
(
[id] => 7018801
[patent_doc_number] => 20050220820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Treatment of holocrine gland dysfunction with clostridia neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 10/524304
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5971
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524304 | Treatment of holocrine gland dysfunction with clostridia neurotoxins | Aug 17, 2003 | Issued |
Array
(
[id] => 7290757
[patent_doc_number] => 20040110681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Method to identify targeting molecules'
[patent_app_type] => new
[patent_app_number] => 10/637718
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15581
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637718 | Method to identify targeting molecules | Aug 7, 2003 | Abandoned |